Guggenheim Sees 41% Upside in Curtiss-Wright as Defense and Nuclear Demand Build
Guggenheim initiated coverage of Curtiss-Wright (NYSE:CW) with a Buy rating and $786 price target, citing 41% upside potential. The firm highlights defense and nuclear demand growth, with Q2 sales up 5% to $924M and EPS up 15% to $3.72. Curtiss-Wright raised its 2026 outlook, expecting 8-9% sales growth and 14-16% EPS growth. However, Guggenheim's target assumes significant appreciation beyond current levels.
How this was made
The 30-second read
Why it matters
Analyst initiation can act as a catalyst, especially for a mid‑cap industrial stock with limited coverage.
Market read
The new target may prompt short‑term buying, but broader market impact is modest.
What to watch
Potential execution risk on the $80 M Cheswick expansion and macro‑defense budget uncertainties.
Background
Curtiss‑Wright reported Q2 sales growth and raised its 2026 outlook, but the article adds Guggenheim’s new coverage and price target.
Ticker impact
Guggenheim initiated coverage with a Buy rating and a $786 price target, implying 41% upside for Curtiss‑Wright.
likely upward pressure as traders price in the 41% upside potential.
The new coverage and target are fresh information that could attract investors, but the company’s recent earnings were already public, limiting the magnitude of the move.
Market effects
Positive outlook for defense and commercial nuclear equipment sector may lift peers.
U.S. defense and energy equipment markets could see modest buying interest.
Limited to investors tracking defense‑nuclear hybrid play.
Counterpoint
The 41% upside may be overstated given already strong Q2 results and higher R&D spend.
Key entities
- companyCurtiss‑Wright Corporation
Industrial manufacturer of defense and nuclear equipment.
- analystGuggenheim Securities
Investment bank that initiated coverage with a Buy rating.
